Terms: = Liver cancer AND NPM1, NPM, 4869, ENSG00000181163, P06748, B23, MGC104254
54 results:
1. Seven oxidative stress-related genes predict the prognosis of hepatocellular carcinoma.
Miao C; He X; Chen G; Kahlert UD; Yao C; Shi W; Su D; Hu L; Zhang Z
Aging (Albany NY); 2023 Dec; 15(24):15050-15063. PubMed ID: 38097352
[TBL] [Abstract] [Full Text] [Related]
2. Progression in Myeloid Neoplasms: Beyond the Myeloblast.
Faria C; Tzankov A
Pathobiology; 2024; 91(1):55-75. PubMed ID: 37232015
[TBL] [Abstract] [Full Text] [Related]
3. Centrosome amplification-related signature correlated with immune microenvironment and treatment response predicts prognosis and improves diagnosis of hepatocellular carcinoma by integrating machine learning and single-cell analyses.
Liu Y; He M; Ke X; Chen Y; Zhu J; Tan Z; Chen J
Hepatol Int; 2024 Feb; 18(1):108-130. PubMed ID: 37154991
[TBL] [Abstract] [Full Text] [Related]
4. XPO1 intensifies sorafenib resistance by stabilizing acetylation of npm1 and enhancing epithelial-mesenchymal transition in hepatocellular carcinoma.
Wang Z; Pan B; Yao Y; Qiu J; Zhang X; Wu X; Tang N
Biomed Pharmacother; 2023 Apr; 160():114402. PubMed ID: 36791564
[TBL] [Abstract] [Full Text] [Related]
5. Non-coding small nucleolar RNA SNORD17 promotes the progression of hepatocellular carcinoma through a positive feedback loop upon p53 inactivation.
Liang J; Li G; Liao J; Huang Z; Wen J; Wang Y; Chen Z; Cai G; Xu W; Ding Z; Liang H; Datta PK; Chu L; Chen X; Zhang B
Cell Death Differ; 2022 May; 29(5):988-1003. PubMed ID: 35034103
[TBL] [Abstract] [Full Text] [Related]
6. What is the likelihood of nonpulmonary metastasis occurring in the absence of lung metastasis in bone and soft tissue sarcoma? A nested case-control from a sarcoma referral centre.
Hasan O; Nasir M; Jessar M; Hashimi M; An Q; Miller BJ
J Surg Oncol; 2021 Dec; 124(8):1491-1498. PubMed ID: 34382687
[TBL] [Abstract] [Full Text] [Related]
7. PSPC1 is a new contextual determinant of aberrant subcellular translocation of oncogenes in tumor progression.
Lang YD; Jou YS
J Biomed Sci; 2021 Aug; 28(1):57. PubMed ID: 34340703
[TBL] [Abstract] [Full Text] [Related]
8. Inhibition of the de novo pyrimidine biosynthesis pathway limits ribosomal RNA transcription causing nucleolar stress in glioblastoma cells.
Lafita-Navarro MC; Venkateswaran N; Kilgore JA; Kanji S; Han J; Barnes S; Williams NS; Buszczak M; Burma S; Conacci-Sorrell M
PLoS Genet; 2020 Nov; 16(11):e1009117. PubMed ID: 33201894
[TBL] [Abstract] [Full Text] [Related]
9. HOPS and p53: thick as thieves in life and death.
Della-Fazia MA; Castelli M; Piobbico D; Pieroni S; Servillo G
Cell Cycle; 2020 Nov; 19(22):2996-3003. PubMed ID: 33112208
[TBL] [Abstract] [Full Text] [Related]
10. Novel FMRP interaction networks linked to cellular stress.
Taha MS; Haghighi F; Stefanski A; Nakhaei-Rad S; Kazemein Jasemi NS; Al Kabbani MA; Görg B; Fujii M; Lang PA; Häussinger D; Piekorz RP; Stühler K; Ahmadian MR
FEBS J; 2021 Feb; 288(3):837-860. PubMed ID: 32525608
[TBL] [Abstract] [Full Text] [Related]
11. A phase 1 study of azacitidine with high-dose cytarabine and mitoxantrone in high-risk acute myeloid leukemia.
Cahill KE; Karimi YH; Karrison TG; Jain N; Green M; Weiner H; Fulton N; Kadri S; Godley LA; Artz AS; Liu H; Thirman MJ; Le Beau MM; McNerney ME; Segal J; Larson RA; Stock W; Odenike O
Blood Adv; 2020 Feb; 4(4):599-606. PubMed ID: 32074275
[TBL] [Abstract] [Full Text] [Related]
12. Network pharmacology-based analysis of mechanisms of the anti-hepatocellular carcinoma effect by dihydroartemisinin.
Liu T; Guo J; Wang T; Zhang S; Yu X; Hou C; Guo D
Discov Med; 2019 Sep; 28(153):139-147. PubMed ID: 31926585
[TBL] [Abstract] [Full Text] [Related]
13. Impact of Intermittent Pringle Maneuver on Long-Term Survival After Hepatectomy for Hepatocellular Carcinoma: Result from Two Combined Randomized Controlled Trials.
Lee KF; Chong CCN; Cheung SYS; Wong J; Fung AKY; Lok HT; Lai PBS
World J Surg; 2019 Dec; 43(12):3101-3109. PubMed ID: 31420724
[TBL] [Abstract] [Full Text] [Related]
14. The cancer driver genes IDH1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism.
Chang S; Yim S; Park H
Exp Mol Med; 2019 Jun; 51(6):1-17. PubMed ID: 31221981
[TBL] [Abstract] [Full Text] [Related]
15. CRISPR genome editing of murine hematopoietic stem cells to create
Rajan SS; Li L; Kweh MF; Kunkalla K; Amin AD; Agarwal NK; Vega F; Schatz JH
Blood Adv; 2019 Jun; 3(12):1788-1794. PubMed ID: 31189527
[TBL] [Abstract] [Full Text] [Related]
16. Does Intermittent Pringle Maneuver Increase Postoperative Complications After Hepatectomy for Hepatocellular Carcinoma? A Randomized Controlled Trial.
Lee KF; Wong J; Cheung SYS; Chong CCN; Hui JWY; Leung VYF; Yu SCH; Lai PBS
World J Surg; 2018 Oct; 42(10):3302-3311. PubMed ID: 29696328
[TBL] [Abstract] [Full Text] [Related]
17. Integrated Analysis of Copy Number Variations and Gene Expression Profiling in Hepatocellular carcinoma.
Zhou C; Zhang W; Chen W; Yin Y; Atyah M; Liu S; Guo L; Shi Y; Ye Q; Dong Q; Ren N
Sci Rep; 2017 Sep; 7(1):10570. PubMed ID: 28874807
[TBL] [Abstract] [Full Text] [Related]
18. Survival outcomes of hepatectomy for stage B Hepatocellular carcinoma in the BCLC classification.
Kamiyama T; Orimo T; Wakayama K; Shimada S; Nagatsu A; Yokoo H; Kamachi H; Yamashita K; Shimamura T; Taketomi A
World J Surg Oncol; 2017 Aug; 15(1):156. PubMed ID: 28830473
[TBL] [Abstract] [Full Text] [Related]
19. CEP131 indicates poor prognosis and promotes cell proliferation and migration in hepatocellular carcinoma.
Liu XH; Yang YF; Fang HY; Wang XH; Zhang MF; Wu DC
Int J Biochem Cell Biol; 2017 Sep; 90():1-8. PubMed ID: 28694105
[TBL] [Abstract] [Full Text] [Related]
20. Tumor-associated autoantibodies are useful biomarkers in immunodiagnosis of α-fetoprotein-negative hepatocellular carcinoma.
Wang T; Liu M; Zheng SJ; Bian DD; Zhang JY; Yao J; Zheng QF; Shi AM; Li WH; Li L; Chen Y; Wang JH; Duan ZP; Dong L
World J Gastroenterol; 2017 May; 23(19):3496-3504. PubMed ID: 28596685
[TBL] [Abstract] [Full Text] [Related]
[Next]